LPL Financial’s Matinas BioPharma MTNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-12,247
| Closed | -$96.9K | – | 5128 |
|
|
2024
Q2 | $96.9K | Hold |
12,247
| – | – | ﹤0.01% | 4651 |
|
|
2024
Q1 | $166K | Sell |
12,247
-24
| -0.2% | -$325 | ﹤0.01% | 4472 |
|
|
2023
Q4 | $133K | Sell |
12,271
-80
| -0.6% | -$865 | ﹤0.01% | 4435 |
|
|
2023
Q3 | $80.3K | Sell |
12,351
-60
| -0.5% | -$390 | ﹤0.01% | 4399 |
|
|
2023
Q2 | $223K | Sell |
12,411
-288
| -2% | -$5.18K | ﹤0.01% | 4025 |
|
|
2023
Q1 | $298K | Hold |
12,699
| – | – | ﹤0.01% | 3724 |
|
|
2022
Q4 | $317K | Buy |
12,699
+300
| +2% | +$7.5K | ﹤0.01% | 3586 |
|
|
2022
Q3 | $394K | Buy |
12,399
+7,099
| +134% | +$226K | ﹤0.01% | 3343 |
|
|
2022
Q2 | $209K | Sell |
5,300
-16
| -0.3% | -$631 | ﹤0.01% | 3884 |
|
|
2022
Q1 | $214K | Sell |
5,316
-238
| -4% | -$9.58K | ﹤0.01% | 3783 |
|
|
2021
Q4 | $280K | Hold |
5,554
| – | – | ﹤0.01% | 3717 |
|
|
2021
Q3 | $361K | Buy |
5,554
+2,435
| +78% | +$158K | ﹤0.01% | 3481 |
|
|
2021
Q2 | $121K | Buy |
3,119
+63
| +2% | +$2.44K | ﹤0.01% | 4005 |
|
|
2021
Q1 | $160K | Buy |
3,056
+366
| +14% | +$19.2K | ﹤0.01% | 3808 |
|
|
2020
Q4 | $183K | Buy |
+2,690
| New | +$183K | ﹤0.01% | 3537 |
|